Posted May. 29, 2013 at 5:25 p.m.

Premium Lock FDA approves two GSK melanoma drugs and bioMerieux companion genetic test

Published: 2013-05-29 17:25:04
Updated: 2013-05-29 17:25:04

Cancer research Cancer research

In gaining regulatory approval on Tafinlar and Mekinist, GSK also gets steps into the arena for personalized medince skin cancer therapies, territory already staked out by Roche. Like Roche's Zelboraf, GSK's two new skin cancer drugs will be administered only to patients that have a particular gene mutation showing that the drug will work for them....

Read More
Read More

WRAL TechWire any time: Twitter, Facebook

Copyright 2014 WRAL TechWire. All rights reserved.
Editor's Blog

Editor's Blog

The latest blog posts from our WRAL TechWire and WRAL editors. Read more articles…

Please Log In to add a comment.

Best of TechWire Insider

Techwire Inside Partners

OUR INSIDERS

Vivek Wadhwa
Commentary
Frank Vinluan
Life science
Dr. Mike Walden
Tech economy
Scroll